LACK OF BIOLOGICAL INTERACTION OF ALPRENOLOL AND SALICYLATE IN MAN

被引:4
作者
JOHNSSON, G
REGARDH, CG
SOLVELL, L
机构
[1] AB HASSLE,RES LABS,GOTHENBURG,SWEDEN
[2] SAHLGRENS HOSP,DEPT MED II,GOTHENBURG,SWEDEN
关键词
D O I
10.1007/BF00561794
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:9 / 14
页数:6
相关论文
共 10 条
[1]   PHARMACOLOGICAL EFFECTS AND SERUM LEVELS OF ORALLY ADMINISTERED ALPRENOLOL IN MAN [J].
ABLAD, B ;
HALLGREN, J ;
SOLVELL, L ;
JOHNSSON, G ;
ERVIK, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1972, 5 (01) :44-&
[2]  
ERVIK M, 1969, ACTA PHARM SUEC, V6, P393
[3]  
JOHANSSON R, 1971, ACTA PHARM SUEC, V8, P59
[4]  
JOHANSSON R, IN PRESS
[5]   BETA-BLOCKING EFFECT AND SERUM LEVELS OF ALPRENOLOL IN MAN AFTER ADMINISTRATION OF ORDINARY AND SUSTAINED RELEASE TABLETS [J].
JOHNSSON, G ;
SJOGREN, J ;
SOLVELL, L .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1971, 3 (02) :74-&
[6]  
JOHNSSON G, 1967, ACTA PHARMACOL TOX, VS 25, P95
[7]   DRUG BIOTRANSFORMATION INTERACTIONS IN MAN .5. ACETAMINOPHEN AND SALICYLIC ACID [J].
LEVY, G ;
REGARDH, CG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (04) :608-&
[8]   DRUG BIOTRANSFORMATION INTERACTIONS IN MAN I - MUTUAL INHIBITION IN GLUCURONIDE FORMATION OF SALICYLIC ACID AND SALICYLAMIDE IN MAN [J].
LEVY, G ;
PROCKNAL, JA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1968, 57 (08) :1330-&
[9]  
LEVY GL, 1972, CLIN PHARMACOL THER, V13, P258
[10]  
WOOLF CM, 1968, PRINCIPLES BIOMETRY